Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alnara Execs Start Anew With Allena; $15 M Series A

This article was originally published in The Pink Sheet Daily

Executive Summary

Former Alnara founders Alexey Margolin and Robert Gallotto have begun a new venture that includes Alnara’s previous investors.

Advertisement

Related Content

Financings Of The Fortnight Looks For A Strong IPO Year To Pick Up Further In Second Half
Alcresta Infused With $10M Series B To Get First Product To Market
Alcresta Infused With $10M Series B To Get First Product To Market
Financings Of The Fortnight: Thiel Looks To Bridge The Pre-Venture Capital Funding Gap For Biotech
Alcresta Launches With Dynamic Business Model; Raises $10M Series A
Alcresta Launches With Dynamic Business Model; Raises $10M Series A
Deals Of The Week: Allena/Althea, Almirall/Menarini, Bausch & Lomb/Ista
Sollpura's Future After No Vote From Panel Might Include More Trials, Adult Indication
Lilly To Buy Alnara And Its Non-Porcine Pancreatic Enzyme Replacement Therapy

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS073050

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel